Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report

BACKGROUND: Benralizumab is a monoclonal antibody targeting the IL-5 receptor used in the treatment of asthma. The use of benralizumab in other conditions is only emerging and could represent a therapeutic option for other eosinophil-associated diseases. Here, we report the case of a patient sufferi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huguenot, Marc, Bruhm, Anne-Catherine, Essig, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125258/
https://www.ncbi.nlm.nih.gov/pubmed/35663093
http://dx.doi.org/10.12998/wjcc.v10.i14.4502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125258/
https://www.ncbi.nlm.nih.gov/pubmed/35663093
http://dx.doi.org/10.12998/wjcc.v10.i14.4502

Ejemplares similares